# A phase II study investigating the safety and efficacy of neoadjuvant atezolizumab in muscle invasive bladder cancer (ABACUS).

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/a-phase-ii-study-investigating-the-safety-and-efficacy-of-neoadjuvant/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Thomas Powles,Alejo Rodríguez‐Vida,Ignacio Durán,Simon J. Crabb,Michiel Simon Van Der Heijden,Albert Font Pous,Gwénaëlle Gravis,Urbano Anido Herranz,Andrew Protheroe,Alain Ravaud,Denis Maillet,María José Méndez-Vidal,Cristina Suárez,Anja Lorch,Cora N. Sternberg,Mark Linch,Shah‐Jalal Sarker,Aaron Prendergast,Kelly Mousa,Daniel Castellano |
| Citations | 90 |
| DOI | 10.1200/jco.2018.36.15_suppl.4506 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2892310850 |
| Type | conference-abstract |
| Year | 2018 |

## Paper authors

- [Shah‐Jalal Sarker](https://scholariq.org/researchers/shah-jalal-sarker/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)

## Paper topics

- [Bladder and Urothelial Cancer Treatments](https://scholariq.org/topics/bladder-and-urothelial-cancer-treatments/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Urinary and Genital Oncology Studies](https://scholariq.org/topics/urinary-and-genital-oncology-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.